3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
70
Neoplasms
13
Neoplasm Metastasis
7
Brain Neoplasms
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Osteitis Deformans
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Inflammatory Breast Neoplasms
2
Glioblastoma
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Bile Duct Neoplasms
2
Interventions
Cyclophosphamide
33
fludarabine phosphate
31
Peripheral Blood Stem Cell Transplantation
28
Whole-Body Irradiation
27
Rituximab
24
Mycophenolic Acid
24
Busulfan
22
Cyclosporine
19
Tacrolimus
17
Etoposide
17
Antilymphocyte Serum
17
Filgrastim
14
Methotrexate
12
Melphalan
12
Radiotherapy
10
Granulocyte Colony-Stimulating Factor
8
Cord Blood Stem Cell Transplantation
8
thymoglobulin
6
Sirolimus
6
Carmustine
6
Flow Cytometry
5
Cytarabine
5
ibritumomab tiuxetan
4
Vincristine
4
Prednisone
4
Polymerase Chain Reaction
4
Methylprednisolone
4
Gene Expression Profiling
4
Dexamethasone
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large-Cell, Immunoblastic
×
Lapatinib
×
Clear all
No trials found.